Rein Therapeutics, Inc. (RNTX) — DEF 14A Filings
All DEF 14A filings from Rein Therapeutics, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Rein Therapeutics Files DEF 14A, Formerly Aileron Therapeutics
— May 12, 2025 Risk: low
Rein Therapeutics, Inc. filed a DEF 14A on May 12, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation and corporate g -
Aileron Therapeutics Sets August 20th Shareholder Meeting
— Jul 9, 2024 Risk: low
Aileron Therapeutics, Inc. filed its definitive proxy statement (DEF 14A) on July 9, 2024, for its annual meeting of stockholders scheduled for August 20, 2024.
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX